Brief, focused overview of JUQ-279 including purpose, key properties, and recommended next steps.
A. Patel¹, L. Kim², R. Hernández³, J. Liu⁴, M. O’Connor¹, S. Gupta⁵, K. Nakamura⁶ ¹Department of Pharmacology, University of Cambridge, UK ²Institute of Molecular Oncology, Seoul National University, South Korea ³Centro de Investigación Biomédica, Universidad Nacional Autónoma de México, Mexico ⁴Department of Chemical Biology, Tsinghua University, China ⁵Division of Cancer Therapeutics, Memorial Sloan Kettering Cancer Center, USA ⁶Pharmaceutical Sciences Research Center, Osaka University, Japan JUQ-279
Maki Hojo (Houjou Maki), a prominent performer known for "mature woman" ( jukujo ) roles. Brief, focused overview of JUQ-279 including purpose, key
One of the challenges in studying JUQ-279 and similar research chemicals is the limited availability of information on their effects, both beneficial and adverse. This underscores the need for comprehensive research that prioritizes safety and efficacy. Future directions for research on JUQ-279 could include detailed pharmacological studies, exploration of its therapeutic potential in preclinical models, and elucidation of its mechanism of action. Collaborative efforts between chemists, pharmacologists, and clinicians will be essential in unlocking the full potential of JUQ-279. Kim², R